LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Historical Holders from Q1 2014 to Q3 2025

Symbol
LFCR on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
37.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
24.3M
Holdings value
$179M
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
98
Number of buys
46
Number of sells
-35
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Greenhaven Road Investment Management, L.P. 9.8% +25% $23M $7.94M 3.62M +52.8% Greenhaven Road Investment Management, L.P. 31 Dec 2024
22NW Fund, LP 7.49% -32.8% $20.8M -$9.72M 2.98M -31.9% 22NW Fund, LP 27 May 2025
BlackRock, Inc. 4.9% -2% $13.5M -$252K 1.83M -1.83% BlackRock, Inc. 30 Sep 2025
David Capital Partners, LLC 4.87% $11.5M 1.8M David Capital Partners, LLC 31 Dec 2024

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 24.3M $179M -$443K $7.36 98
2025 Q2 24.4M $198M +$13.3M $8.12 84
2025 Q1 22.8M $160M -$2.33M $7.04 85
2024 Q4 23M $171M +$31.4M $7.43 74
2024 Q3 18.9M $93.3M +$960K $4.93 80
2024 Q2 18.6M $95.4M -$6.05M $5.13 73
2024 Q1 21.5M $114M +$1.28M $5.31 75
2023 Q4 21.2M $131M +$7.75M $6.19 77
2023 Q3 17.6M $132M -$4.24M $7.55 67
2023 Q2 18M $174M -$23.6M $9.67 73
2023 Q1 21.6M $81.7M -$19.2M $3.78 79
2022 Q4 24.7M $160M -$421K $6.48 92
2022 Q3 24.8M $220M -$5.08M $8.89 84
2022 Q2 25.3M $252M -$4.81M $9.97 86
2022 Q1 23.5M $272M -$4.45M $11.58 94
2021 Q4 25.9M $287M +$3.1M $11.10 95
2021 Q3 25.5M $235M +$11.3M $9.22 91
2021 Q2 25.6M $288M -$5.84M $11.25 95
2021 Q1 26M $275M -$6.2M $10.60 92
2020 Q4 26.5M $288M -$1.87M $10.85 95
2020 Q3 27.3M $265M +$8.4M $9.72 95
2020 Q2 26.8M $213M -$2.39M $7.96 91
2020 Q1 27.1M $235M -$2.45M $8.69 87
2019 Q4 27.1M $306M +$279K $11.31 92
2019 Q3 26.5M $288M -$10.6M $10.87 102
2019 Q2 27.5M $258M +$10M $9.37 98
2019 Q1 26.3M $323M +$5.33M $12.28 90
2018 Q4 25.9M $306M -$563K $11.84 88
2018 Q3 25.7M $367M -$2.82M $14.40 89
2018 Q2 25.1M $374M -$6.66M $14.90 89
2018 Q1 26.3M $343M +$5.9M $13.05 88
2017 Q4 25.8M $325M -$305K $12.60 90
2017 Q3 25.8M $334M +$6.04M $12.95 92
2017 Q2 25.3M $376M +$3.37M $14.85 92
2017 Q1 25.1M $301M +$26.8M $12.00 83
2016 Q4 24.7M $340M -$4.32M $13.80 91
2016 Q3 25M $336M -$8.28M $13.41 90
2016 Q2 25.7M $277M +$14M $10.76 92
2016 Q1 25.1M $263M +$7.5M $10.50 91
2015 Q4 24.4M $289M +$6.28M $11.83 106
2015 Q3 23.8M $277M -$6.25M $11.67 108
2015 Q2 24.2M $350M -$429K $14.43 107
2015 Q1 24M $335M -$392K $13.95 97
2014 Q4 24.1M $333M -$1.27M $13.81 105
2014 Q3 24.3M $295M +$2.81M $12.25 105
2014 Q2 24M $299M +$4.22M $12.49 99
2014 Q1 23.7M $264M -$9.51M $11.16 96